研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

"Editor-in-Chief's Top Picks From 2022." 主编的2022年度首选。

Editor-in-Chief's Top Picks From 2022.

发表日期:2023 Feb 28
作者: Valentin Fuster
来源: J Am Coll Cardiol

摘要:

每周,我为JACC的每篇论文记录音频摘要,以及一篇问题摘要。由于它们需要的时间,这个过程已经成为一项真正的热爱之工,但我受到了数量庞大的听众(1600万以上)的鼓励,它让我熟悉了我们发表的每篇论文。因此,每年我会从不同的专业中选择前100篇文章(原创研究和评论文章)。除了我的个人选择外,我还包括了在我们网站上被访问或下载最多的文章,以及由JACC编辑委员会成员选择的文章。为了以易于消化的方式呈现这些重要研究的全部广度,我们将在这期JACC中呈现这些摘要,以及它们的中央插图和播客。亮点包括以下几个部分:基础和翻译研究、心脏衰竭和心肌炎、心肌病和遗传学、心脏肿瘤学、先天性心脏病、冠心病和介入、冠状病毒、高血压、影像学、代谢和脂质障碍、神经血管疾病和痴呆、促进健康和预防、节律失常和血栓栓塞、以及瓣膜心脏病。1-100版权所有©2023年美国心脏病学会基金会。由Elsevier Inc.出版。保留所有权利。
Each week, I record audio summaries for every paper in JACC, as well as an issue summary. This process has become a true labor of love due to the time they require, but I am motivated by the sheer number of listeners (16 million plus), and it has allowed me to familiarize myself with every paper that we publish. Thus, I have selected the top 100 papers (both Original Investigations and Review Articles) from distinct specialties each year. In addition to my personal choices, I have included papers that have been the most accessed or downloaded on our websites, as well as those selected by the JACC Editorial Board members. In order to present the full breadth of this important research in a consumable fashion, we will present these abstracts in this issue of JACC, as well as their Central Illustrations and podcasts. The highlights comprise the following sections: Basic & Translational Research, Cardiac Failure & Myocarditis, Cardiomyopathies & Genetics, Cardio-Oncology, Congenital Heart Disease, Coronary Disease & Interventions, Coronavirus, Hypertension, Imaging, Metabolic & Lipid Disorders, Neurovascular Disease & Dementia, Promoting Health & Prevention, Rhythm Disorders & Thromboembolism, and Valvular Heart Disease.1-100.Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.